Advertisement
News
Subscribe to MDT Magazine News

Texas Independent Drugstore Lobby (Continues) Putting Profits Ahead of Patients

April 6, 2011 9:38 am | by Bio-Medicine.Org | Comments

WASHINGTON, April 6, 2011 /PRNewswire-USNewswire/ -- To help reduce state Medicaid spending and save taxpayers $84 million, Governor Rick Perry (R) has proposed that the program's prescription drug benefits be operated more like those in the private sector that are more affordable and...

TOPICS:

Smith & Nephew Endoscopy unit marks medical device milestone

April 6, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The Andover-based Endoscopy division of Smith & Nephew plc, a medical devices firm with headquarters in London, has had its flagship product, the TRUCLEAR System, hit 30,000 procedures.

TOPICS:

LabCorp in $85.4M deal for DNA testing company

April 6, 2011 8:45 am | by The Associated Press | Comments

Laboratory Corp. of America Holdings said Wednesday it agreed to acquire all shares of DNA and paternity testing services company Orchid Cellmark Inc. for $85.4 million, or $2.80 per share.LabCorp, a clinical lab services company based in Burlington, N.C., said it expects the deal to close...

Advertisement

Neural guidance gene regulates liver development

April 6, 2011 8:39 am | by EurekAlert | Comments

(Helmholtz Association of German Research Centres) Scientists of the Max Delbrueck Center in Berlin have demonstrated for the first time that a gene regulating neuronal cell migration during embryogenesis also plays a role in liver development. Using zebrafish as a model organism,...

TOPICS:

Most recent mammography recommendations confuse public

April 6, 2011 8:39 am | by EurekAlert | Comments

(Elsevier Health Sciences) When the USPSTF released its recommendations on mammography screenings for US women on Nov. 16, 2009, there was immediate and considerable controversy. In a study published in the American Journal of Preventive Medicine, investigators report that these...

TOPICS:

PMA Final Decisions for February 2011

April 6, 2011 8:38 am | by U.S. Food & Drug Administration | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for February 2011.

Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010

April 6, 2011 8:37 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- TriMarkPublications.com cites in its newly published " Medical Imaging Markets" report that global spending on medical imaging equipment exceeded $21 billion in 2010. For more information, visit:...

TOPICS:

United Nations Urged to Ban Mercury in Vaccines

April 6, 2011 8:36 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 6, 2011 /PRNewswire-USNewswire/ -- CoMeD – While the United Nations (UN) actively questions the use of vaccines containing a neurotoxic mercury compound, the Coalition for Mercury-Free Drugs (CoMeD), a Maryland-based, non-profit organization, is urging the...

TOPICS:
Advertisement

KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to...

TOPICS:

MIT's Koch Institute to use Roche LightCycler 480 System to Help Advance Cancer Research

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, April 6,  2011 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler ® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of...

TOPICS:

Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

MALIBU, Calif., April 6, 2011 /- Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of...

TOPICS:

An international study in China finds strawberries may slow precancerous growth in the esophagus

April 6, 2011 7:38 am | by EurekAlert | Comments

(Ohio State University Medical Center) Eating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer...

TOPICS:

Yervoy (ipilimumab): Risk Evaluation and Mitigation Strategy (REMS) - Severe Immune-Mediated Adverse Reactions

April 6, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

The most common severe reactions include enterocolitis, hepatitis, dermatitis (including toxic epidermal necrolysis), neuropathy, and endocrinopathy.

TOPICS:

FDA Clears Mandometer® for the Treatment of Eating Disorders

April 6, 2011 6:39 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- The U.S. Food and Drug Administration announced on March 31 that it had cleared Mandometer® for the treatment of patients with eating disorders.   Mandometer® is an innovative device that provides biofeedback allowing individuals to monitor their...

TOPICS:

Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results

April 6, 2011 6:37 am | by Bio-Medicine.Org | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., April 6, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ), and Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced the publication of Phase III PROCHIEVE® (progesterone gel) data in today's online version of Ultrasound in Obstetrics...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading